查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585680

生物技術服務市場：按服務類型、最終用戶分類 - 全球預測 2025-2030

Biotechnology Services Market by Service Type, End-Users (Biotechnology Companies, Clinical Research Organizations, Contract Manufacturers Organizations ) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物技術服務市值為1,930.5億美元，預計到2024年將達到2,146.9億美元，複合年成長率為11.60%，到2030年將達到4,162.5億美元。

生物技術服務市場涵蓋旨在支持生命科學公司和改進醫療解決方案的廣泛服務，包括生物加工、藥物發現、DNA定序、基因組學和蛋白​​質組學。對這些服務的需求源於對個人化醫療不斷成長的需求、生物製藥的突破以及對創新醫療解決方案的迫切需求。這些服務應用於藥物和生物技術產品開發的各個階段，從研究和臨床前測試到監管核准和上市後監督，為研究機構、醫療保健提供者和製藥公司等組織提供支援。該市場的關鍵成長要素包括基因工程的進步、生物技術研發的大力投資以及需要創新治療的慢性病的流行。 CRISPR技術、再生醫學、生物資訊學等領域充滿商機。相關人員可以透過投資聯合夥伴關係、加強服務組合和關注新興市場來利用這些優勢。然而，存在阻礙市場擴張的限制，包括嚴格的監管環境、高昂的營運成本以及圍繞基因改造的倫理問題。此外，獲得熟練專家的協助和資料管理挑戰也是主要障礙。具有巨大業務成長潛力的創新研發領域包括開發負擔得起的定序方法、簡化生物流程以及將人工智慧和機器學習整合到藥物發現中進行預測分析。對於市場參與企業和現有企業而言，對市場動態的研究揭示了一個充滿希望但競爭激烈的格局，其中適應性、技術力和策略聯盟對於持續成長至關重要。此外，注重以患者為中心的方法和永續性實踐可以提供明顯的優勢，符合綠色和人性化的醫療保健解決方案的全球趨勢。總體而言，生物技術服務市場是一個充滿活力的環境，對於那些準備好透過創新策略應對複雜情況的人來說充滿了可能性。

主要市場統計
基準年[2023] 1930.5億美元
預測年份 [2024] 2146.9億美元
預測年份 [2030] 4162.5億美元
複合年成長率（%） 11.60%

市場動態：揭示快速發展的生物技術服務市場的關鍵市場洞察

供需的動態交互作用正在改變生物技術服務市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 製藥公司增加藥物開發業務外包
    • 學術研究活動的活性化和高效設施的需求
    • 不斷擴大合約研究和製造服務
  • 市場限制因素
    • 對外包服務的績效、品質和保密性的擔憂
  • 市場機會
    • 生物技術設備和技術的進步
    • 活性化生物技術研究的資金籌措和投資活動
  • 市場問題
    • 生物技術外包服務嚴格的監管合規要求

波特五力：駕馭生技服務市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解生物技術服務市場的外部影響

外部宏觀環境因素在塑造生物技術服務市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解生物技術服務市場的競爭格局

生物技術服務市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣生物技術服務市場供應商的績效評估

FPNV 定位矩陣是評估生物技術服務市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：制定生物技術服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，生物技術服務市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥公司增加藥物開發業務外包
      • 學術研究活動的增加和對高效設施的需求
      • 擴大合約研究和製造服務
    • 抑制因素
      • 對外包服務的績效、品質和保密性的擔憂
    • 機會
      • 生物技術設備和技術的進步
      • 生物技術研究的新資金籌措和投資活動
    • 任務
      • 生技外包服務嚴格合規
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章生物技術服務市場：依服務類型

  • 介紹
  • 細胞處理和分離
  • 招募捐款者
  • 食品生物技術服務
  • 預防和疾病控制
  • 公共參與活動
  • 組織收集

第7章生物技術服務市場：依最終用戶分類

  • 介紹
  • 生技公司
  • 臨床研究組織（CRO）
  • 契約製造組織 (CMO)

第8章美洲生物技術服務市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太生物技術服務市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲生物技術服務市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Almac Group Limited
  • AnaBioTec NV
  • Avance Clinical Pty Ltd.
  • Azenta Life Sciences
  • Becton, Dickinson and Company
  • Biogen Inc.
  • BioIVT LLC
  • Caidya
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • CMIC Group
  • Contract Pharmacal Corp.
  • Crown Bioscience, Inc.
  • Danaher Corporation
  • Eurofins Scientific Limited
  • GE HealthCare Technologies Inc.
  • GenScript BIoTech Corporation
  • ICON PLC
  • ITR Laboratories Canada
  • Kaneka Corporation
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Novartis AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
Product Code: MRR-521BAA36EA71

The Biotechnology Services Market was valued at USD 193.05 billion in 2023, expected to reach USD 214.69 billion in 2024, and is projected to grow at a CAGR of 11.60%, to USD 416.25 billion by 2030.

The Biotechnology Services market encompasses a wide range of services such as bioprocessing, drug discovery, DNA sequencing, genomics, and proteomics, aimed at supporting life sciences companies and advancing healthcare solutions. The necessity for these services arises from the increasing demand for personalized medicine, breakthroughs in biopharmaceuticals, and the pressing need for innovative healthcare solutions. These services are applied across various stages of pharmaceutical and biotechnological product development, from research and pre-clinical trials to regulatory approvals and post-market studies, supporting organizations like research institutions, healthcare providers, and pharmaceutical companies. Key growth influencers in this market include advancements in genetic engineering, robust investments in biotechnology R&D, and a growing prevalence of chronic diseases necessitating innovative treatments. Opportunities abound in areas such as CRISPR technology, regenerative medicine, and bioinformatics; stakeholders can harness these by investing in collaborative partnerships, enhancing service portfolios, and focusing on emerging markets. Nonetheless, limitations persist, such as stringent regulatory landscapes, high operational costs, and ethical concerns around genetic modifications, which can impede market expansion. Additionally, access to skilled professionals and data management challenges present significant hurdles. Innovative research areas with high potential for business growth include developing affordable sequencing methods, improving bioprocessing efficiencies, and integrating AI and machine learning for predictive analytics in drug discovery. For market entrants and existing players, insights into market dynamics reveal a promising but competitive landscape where adaptability, technological prowess, and strategic alliances will be essential for sustained growth. Emphasizing patient-centric approaches and sustainability practices may also offer distinct advantages in line with global trends towards eco-conscious and human-centered healthcare solutions. Overall, the biotechnology services market presents a vibrant environment ripe with potential for those ready to navigate its complexities with innovative strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 193.05 billion
Estimated Year [2024] USD 214.69 billion
Forecast Year [2030] USD 416.25 billion
CAGR (%) 11.60%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotechnology Services Market

The Biotechnology Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing outsourcing of drug development activities by pharmaceutical companies
    • Growing rate of academic research activities and need for efficient facilities
    • Rising expansion of contract research and manufacturing services
  • Market Restraints
    • Concerns over performance, quality and confidentiality of outsourcing services
  • Market Opportunities
    • Advancements in biotechnology instruments and techniques
    • Emerging funding and investment activities in biotechnology research
  • Market Challenges
    • Stringent regulatory compliances for biotechnology outsourcing services

Porter's Five Forces: A Strategic Tool for Navigating the Biotechnology Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotechnology Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotechnology Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotechnology Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotechnology Services Market

A detailed market share analysis in the Biotechnology Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotechnology Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotechnology Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotechnology Services Market

A strategic analysis of the Biotechnology Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Almac Group Limited, AnaBioTec NV, Avance Clinical Pty Ltd., Azenta Life Sciences, Becton, Dickinson and Company, Biogen Inc., BioIVT LLC, Caidya, Catalent, Inc., Charles River Laboratories International, Inc., CMIC Group, Contract Pharmacal Corp., Crown Bioscience, Inc., Danaher Corporation, Eurofins Scientific Limited, GE HealthCare Technologies Inc., GenScript Biotech Corporation, ICON PLC, ITR Laboratories Canada, Kaneka Corporation, Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Biotechnology Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service Type, market is studied across Cell Processing & Isolation, Donor Recruitment, Food Biotechnology Services, Prevention & Disease Control, Public Engagement Activities, and Tissue Collection.
  • Based on End-Users, market is studied across Biotechnology Companies, Clinical Research Organizations(CROs), and Contract Manufacturers Organizations (CMOs).
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing outsourcing of drug development activities by pharmaceutical companies
      • 5.1.1.2. Growing rate of academic research activities and need for efficient facilities
      • 5.1.1.3. Rising expansion of contract research and manufacturing services
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over performance, quality and confidentiality of outsourcing services
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in biotechnology instruments and techniques
      • 5.1.3.2. Emerging funding and investment activities in biotechnology research
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory compliances for biotechnology outsourcing services
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biotechnology Services Market, by Service Type

  • 6.1. Introduction
  • 6.2. Cell Processing & Isolation
  • 6.3. Donor Recruitment
  • 6.4. Food Biotechnology Services
  • 6.5. Prevention & Disease Control
  • 6.6. Public Engagement Activities
  • 6.7. Tissue Collection

7. Biotechnology Services Market, by End-Users

  • 7.1. Introduction
  • 7.2. Biotechnology Companies
  • 7.3. Clinical Research Organizations(CROs)
  • 7.4. Contract Manufacturers Organizations (CMOs)

8. Americas Biotechnology Services Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biotechnology Services Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Services Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Almac Group Limited
  • 3. AnaBioTec NV
  • 4. Avance Clinical Pty Ltd.
  • 5. Azenta Life Sciences
  • 6. Becton, Dickinson and Company
  • 7. Biogen Inc.
  • 8. BioIVT LLC
  • 9. Caidya
  • 10. Catalent, Inc.
  • 11. Charles River Laboratories International, Inc.
  • 12. CMIC Group
  • 13. Contract Pharmacal Corp.
  • 14. Crown Bioscience, Inc.
  • 15. Danaher Corporation
  • 16. Eurofins Scientific Limited
  • 17. GE HealthCare Technologies Inc.
  • 18. GenScript Biotech Corporation
  • 19. ICON PLC
  • 20. ITR Laboratories Canada
  • 21. Kaneka Corporation
  • 22. Laboratory Corporation of America Holdings
  • 23. Merck KGaA
  • 24. Novartis AG
  • 25. Siemens Healthcare GmbH
  • 26. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. BIOTECHNOLOGY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOTECHNOLOGY SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOTECHNOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOTECHNOLOGY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOTECHNOLOGY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOTECHNOLOGY SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CELL PROCESSING & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DONOR RECRUITMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY FOOD BIOTECHNOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PREVENTION & DISEASE CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PUBLIC ENGAGEMENT ACTIVITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TISSUE COLLECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS(CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONTRACT MANUFACTURERS ORGANIZATIONS (CMOS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. BIOTECHNOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. BIOTECHNOLOGY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023